Stock Ticker

  • Loading stock data...

Seattle Genetics, Inc (NASDAQ:SGEN) Impressed After Receiving Positive Data For Adcetris

Seattle Genetics, Inc (NASDAQ:SGEN) and Takeda Pharmaceutical Company Limited are the main newsmakers today after they announce positive results in regards to the phase III study, ECHLEON 1 study. It was set up in a bid to evaluate Adcetris (brentuximab vedotin) as part of a frontline combination chemotherapy regimen in the different persons diagnosed with […]

OncBioMune Pharmaceuticals Inc (OTCMKTS:OBMP) making strides in the $7.1 billion prostate cancer treatment space

OncBioMune Pharmaceuticals Inc (OTCMKTS:OBMP), a biopharmaceutical company making strides in the $7.1 billion prostate cancer treatment space, has continued to show very strong action on the charts so far in 2017, up more than 100% in a little over five weeks of action. We have been closely watching the company this year, and can offer […]

A New Angle To The Latest Endocyte, Inc. (NASDAQ:ECYT) Story

Boston, MA 03/21/2014 (wallstreetpr) – Endocyte, Inc. (NASDAQ:ECYT) announced that its lung cancer drug candidate showed positive results in patients during the mid-stage study. The company also announced recommendation for the use of the drug in the treatment of ovarian cancer patients in Europe. Shares of the company gained significantly on the back of the positive […]

Sign Up To Get Our Latest Stocks Alerts